In the United States, 175mm people currently suffer from Degenerative, Traumatic, Psychiatric and Developmental brain disorders.
Traditional treatments for these conditions are more than
$830bn annually with up to a 99% failure rate. Thankfully, NeuroCep
provides an affordable home use solution – one which offers hope today.
-
Preventative
DAMAGE CONTROL & NEURO PROTECION.
Treatment before an adverse event has been shown to minimize both initial and secondary damage
sustained in the brain.A promising prophylactic for contact sports and military use. Aiding in the prevention or limitation of
Concussions, TBI, & CTE. -
Degenerative
DEMENTIA, ALZHEIMERS (AD), PARKINSON’S (PD)
Clinical trials have shown significant improvement in just weeks. Better sleep, improvements in mobility & speech, reduced aggression, less wandering & reduction in Dementia, AD & PD.
“Light Therapy…7x more effective than Aricept, the leading Alzheimer’s medication.” Dr. Hamblin, Harvard
-
Traumatic
TRAUMATIC BRAIN INJURY (TBI), CHRONIC TRAUMATIC ENCEPHALOPATHY (CTE), GLOBAL ISCHEMIA (STROKE, COMA)
Clinical trials on High Achieving individuals with TBI demonstrated improved Memory, reading and Mathematical skills.
Improved Paralysis & Spacticity was observed in patients with mild to moderate stroke.
-
Psychiatric
INSOMNIA, PTSD, DEPRESSION, ADDICTION.
Clinical trials demonstrate better anger management, improved self awareness & self regulation in social and work settings. Less depression and anxiety combined with less opiod cravings can be detected in as little as two weeks.
68% of women and 56% of men lose sleep due to stress or anxiety.
-
Developmental
AUTISM & ADHD.
Clinical trials on individual’s with mild to moderate cases have shown improvements in both the Responsiveness & Global Impression scales.
Health & Human Services has stated that the earlier children are diagnosed and receive services, the better their outcomes are.